These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

787 related items for PubMed ID: 17489053

  • 1. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD, Shvartzman P, Friger M, Fich A.
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT, Färkkilä MA.
    Aliment Pharmacol Ther; 2004 Aug 01; 20(3):339-45. PubMed ID: 15274671
    [Abstract] [Full Text] [Related]

  • 3. Irritable bowel syndrome and the Rome III criteria: for better or for worse?
    Gwee KA.
    Eur J Gastroenterol Hepatol; 2007 Jun 01; 19(6):437-9. PubMed ID: 17489052
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of irritable bowel syndrome among undergraduates in Southeast China.
    Dai N, Cong Y, Yuan H.
    Dig Liver Dis; 2008 Jun 01; 40(6):418-24. PubMed ID: 18339591
    [Abstract] [Full Text] [Related]

  • 5. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice?
    Boyce PM, Koloski NA, Talley NJ.
    Am J Gastroenterol; 2000 Nov 01; 95(11):3176-83. PubMed ID: 11095338
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.
    Bommelaer G, Dorval E, Denis P, Czernichow P, Frexinos J, Pelc A, Slama A, El Hasnaoui A.
    Gastroenterol Clin Biol; 2002 Dec 01; 26(12):1118-23. PubMed ID: 12520200
    [Abstract] [Full Text] [Related]

  • 7. Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women.
    Chey WD, Olden K, Carter E, Boyle J, Drossman D, Chang L.
    Am J Gastroenterol; 2002 Nov 01; 97(11):2803-11. PubMed ID: 12425552
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
    Han SH, Lee OY, Bae SC, Lee SH, Chang YK, Yang SY, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH, Kim TH.
    J Gastroenterol Hepatol; 2006 Nov 01; 21(11):1687-92. PubMed ID: 16984590
    [Abstract] [Full Text] [Related]

  • 9. Unexpectedly low prevalence rates of IBS among adult Israeli Jews.
    Sperber AD, Shvartzman P, Friger M, Fich A.
    Neurogastroenterol Motil; 2005 Apr 01; 17(2):207-11. PubMed ID: 15787941
    [Abstract] [Full Text] [Related]

  • 10. Stability of irritable bowel syndrome using a Rome II-based classification.
    Williams RE, Black CL, Kim HY, Andrews EB, Mangel AW, Buda JJ, Cook SF.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):197-205. PubMed ID: 16393298
    [Abstract] [Full Text] [Related]

  • 11. Value of different diagnostic criteria for the irritable bowel syndrome among men and women.
    Hammer J, Talley NJ.
    J Clin Gastroenterol; 2008 Feb 01; 42(2):160-6. PubMed ID: 18209586
    [Abstract] [Full Text] [Related]

  • 12. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B, Pourhoseingholi MA, Safaee A, Moghimi-Dehkordi B, Sedigh-Tonekaboni B, Pourhoseingholi A, Habibi M, Zali MR.
    J Gastrointestin Liver Dis; 2009 Dec 01; 18(4):413-8. PubMed ID: 20076812
    [Abstract] [Full Text] [Related]

  • 13. A population-based epidemiologic study of irritable bowel syndrome in South China: stratified randomized study by cluster sampling.
    Xiong LS, Chen MH, Chen HX, Xu AG, Wang WA, Hu PJ.
    Aliment Pharmacol Ther; 2004 Jun 01; 19(11):1217-24. PubMed ID: 15153175
    [Abstract] [Full Text] [Related]

  • 14. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact.
    Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V.
    Aliment Pharmacol Ther; 2005 Jun 01; 21(11):1365-75. PubMed ID: 15932367
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of irritable bowel syndrome: a community survey.
    Wilson S, Roberts L, Roalfe A, Bridge P, Singh S.
    Br J Gen Pract; 2004 Jul 01; 54(504):495-502. PubMed ID: 15239910
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome.
    Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ.
    Am J Gastroenterol; 2000 Oct 01; 95(10):2816-24. PubMed ID: 11051354
    [Abstract] [Full Text] [Related]

  • 17. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A, Posserud I, Abrahamsson H, Simrén M.
    Aliment Pharmacol Ther; 2007 Sep 15; 26(6):953-61. PubMed ID: 17767480
    [Abstract] [Full Text] [Related]

  • 18. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A, Liao X, Xiong L, Peng S, Xiao Y, Liu S, Hu P, Chen M.
    BMC Gastroenterol; 2008 Sep 23; 8():43. PubMed ID: 18808723
    [Abstract] [Full Text] [Related]

  • 19. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM, Holtmann G.
    J Gastroenterol Hepatol; 2008 Jul 23; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [Abstract] [Full Text] [Related]

  • 20. Societal costs for irritable bowel syndrome--a population based study.
    Hillilä MT, Färkkilä NJ, Färkkilä MA.
    Scand J Gastroenterol; 2010 May 23; 45(5):582-91. PubMed ID: 20166844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.